Aspasia Stamatoullas‐Bastard

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani et al. · Blood · 2017 · 236 citations · Full text

Medicine, Hematology, Immunology +16

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Frédérik Damm, Olivier Kosmider, Véronique Gelsi‐Boyer et al. · Blood · 2012 · 231 citations

Life Sciences, Molecular Biology, Molecular Genetics +16

Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B

J L Harousseau, A. W. Dekker, Aspasia Stamatoullas‐Bastard et al. · Antimicrobial Agents and Chemotherapy · 2000 · 157 citations

Medicine, Infectious Diseases, Pharmacology +16

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi, Julia Gilhodes, Marie Maerevoet et al. · American Journal of Hematology · 2018 · 122 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Survival after Hodgkin lymphoma

Olav Favier, Natacha Heutte, Aspasia Stamatoullas‐Bastard et al. · Cancer · 2009 · 76 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13